Characteristics and predictors of short-term mortality in decompensated cirrhotic patients with acute-on-chronic liver failure.

IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Clinical and Experimental Hepatology Pub Date : 2022-12-01 DOI:10.5114/ceh.2022.122332
Ahmed Abudeif, Eman Khalifa Al Sayed, Ghada Moustapha Galal
{"title":"Characteristics and predictors of short-term mortality in decompensated cirrhotic patients with acute-on-chronic liver failure.","authors":"Ahmed Abudeif,&nbsp;Eman Khalifa Al Sayed,&nbsp;Ghada Moustapha Galal","doi":"10.5114/ceh.2022.122332","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim of the study: </strong>We aimed to investigate the characteristics of acute-on-chronic liver failure (ACLF) and factors associated with 28-day mortality in patients with ACLF.</p><p><strong>Material and methods: </strong>This prospective study included ACLF patients based on the European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium criteria, admitted between March 2021 and February 2022. We examined variables associated with 28-day mortality using multivariate Cox regression analysis.</p><p><strong>Results: </strong>Of 326 patients admitted with acute decompensation (AD) of cirrhosis, 109 (33.44%) patients were diagnosed with ACLF (mean age 63.61 ±11.15 years, 65.14% males). Of these, 26.61%, 35.78%, and 37.61% of patients were in ACLF grades 1, 2, and 3 respectively. HCV (80.73%) was the main aetiology of cirrhosis. Upper gastrointestinal bleeding (25.69%) was the most common trigger. Kidney failure (73.39%) was the most common organ failure. The 28-day mortality rate was 66.97%. Cox regression analysis revealed that the existence of 2 (HR = 6.99, 95% CI: 2.68-18.25, <i>p</i> < 0.0001) or ≥ 3 (HR = 9.34, 95% CI: 3.6-24.74, <i>p</i> < 0.0001) organ failures, hepatic encephalopathy (HR = 2.96, 95% CI: 1.27-6.94, <i>p</i> = 0.01), and elevated serum bilirubin (HR = 1.03, 95% CI: 1.00-1.06, <i>p</i> = 0.04) were independent predictors for 28-day mortality, while shifting blood pH to the normal range was associated with a decrease in the HR of ACLF mortality (HR = 0.03, 95% CI: 0.002-0.44, <i>p</i> = 0.01).</p><p><strong>Conclusions: </strong>ACLF has a very high 28-day mortality, which is associated with the existence of 2 or more organ failures, hepatic encephalopathy, elevated serum bilirubin, and low blood pH.</p>","PeriodicalId":10281,"journal":{"name":"Clinical and Experimental Hepatology","volume":"8 4","pages":"300-308"},"PeriodicalIF":1.7000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e7/4b/CEH-8-48689.PMC9850305.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ceh.2022.122332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim of the study: We aimed to investigate the characteristics of acute-on-chronic liver failure (ACLF) and factors associated with 28-day mortality in patients with ACLF.

Material and methods: This prospective study included ACLF patients based on the European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium criteria, admitted between March 2021 and February 2022. We examined variables associated with 28-day mortality using multivariate Cox regression analysis.

Results: Of 326 patients admitted with acute decompensation (AD) of cirrhosis, 109 (33.44%) patients were diagnosed with ACLF (mean age 63.61 ±11.15 years, 65.14% males). Of these, 26.61%, 35.78%, and 37.61% of patients were in ACLF grades 1, 2, and 3 respectively. HCV (80.73%) was the main aetiology of cirrhosis. Upper gastrointestinal bleeding (25.69%) was the most common trigger. Kidney failure (73.39%) was the most common organ failure. The 28-day mortality rate was 66.97%. Cox regression analysis revealed that the existence of 2 (HR = 6.99, 95% CI: 2.68-18.25, p < 0.0001) or ≥ 3 (HR = 9.34, 95% CI: 3.6-24.74, p < 0.0001) organ failures, hepatic encephalopathy (HR = 2.96, 95% CI: 1.27-6.94, p = 0.01), and elevated serum bilirubin (HR = 1.03, 95% CI: 1.00-1.06, p = 0.04) were independent predictors for 28-day mortality, while shifting blood pH to the normal range was associated with a decrease in the HR of ACLF mortality (HR = 0.03, 95% CI: 0.002-0.44, p = 0.01).

Conclusions: ACLF has a very high 28-day mortality, which is associated with the existence of 2 or more organ failures, hepatic encephalopathy, elevated serum bilirubin, and low blood pH.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
失代偿肝硬化合并急性-慢性肝功能衰竭患者短期死亡率的特征和预测因素。
研究目的:我们旨在研究急性慢性肝衰竭(ACLF)的特征以及与ACLF患者28天死亡率相关的因素。材料和方法:这项前瞻性研究纳入了2021年3月至2022年2月期间入院的基于欧洲肝脏-慢性肝衰竭研究协会(EASL-CLIF)联盟标准的ACLF患者。我们使用多变量Cox回归分析检查了与28天死亡率相关的变量。结果:326例肝硬化急性失代偿(AD)患者中,109例(33.44%)诊断为ACLF(平均年龄63.61±11.15岁,男性65.14%)。其中,26.61%、35.78%和37.61%的患者分别为ACLF 1级、2级和3级。HCV(80.73%)是肝硬化的主要病因。上消化道出血(25.69%)是最常见的诱因。肾功能衰竭(73.39%)是最常见的器官衰竭。28天死亡率为66.97%。Cox回归分析表明,2的存在(HR = 6.99, 95%置信区间CI: 2.68 - -18.25, p < 0.0001)或≥3 (HR = 9.34, 95%置信区间CI: 3.6 - -24.74, p < 0.0001)器官衰竭,肝性脑病(HR = 2.96, 95%置信区间CI: 1.27 - -6.94, p = 0.01),和血清胆红素升高(HR = 1.03, 95%置信区间CI: 1.00 - -1.06, p = 0.04) 28天死亡率的独立预测因素,转而将血液pH值在正常范围内,减少ACLF死亡率的人力资源(HR = 0.03, 95%置信区间CI: 0.002 - -0.44, p = 0.01)。结论:ACLF具有非常高的28天死亡率,这与存在2种或2种以上器官衰竭、肝性脑病、血清胆红素升高和低血pH值有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical and Experimental Hepatology
Clinical and Experimental Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
2.80
自引率
0.00%
发文量
32
期刊介绍: Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.
期刊最新文献
Drug-induced liver injury. Part II: Late complications and hepatotoxicity monitoring. Clinical characteristics and risk factors of metabolic dysfunction-associated steatotic liver disease in lean patients: results of the Polish Gallstone Surgery Registry. Association between metabolic associated fatty liver disease and HCC risk after SVR in HCV patients: A systematic review and meta-analysis. Serum ascites albumin gradient in predicting the severity of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1